Overview of all RIVM reports and publications concerning DNA and public health.

Technological developments in DNA research are progressing rapidly. New developments often raise questions about ethics, laws and regulations, and what society considers important.

In recent decades, much research has been conducted on the use of DNA and its potential for public health and care. On this page, we explain this further and show the work of RIVM in this regard.

To ensure effective treatment and a timely response, it is important to identify early on whether someone has a condition or is at risk of developing one. This can be done in different ways. For example, through government-led programmes such as newborn blood spot screening, population cancer screening and non-invasive prenatal testing (NIPT). The NIPT, for example, is based on a DNA test.

We want everyone to be able to take part in society. It follows that our websites should reflect that ambition. That is why we pay considerable attention to accessibility, user-friendliness and findability. We aim to present all information in such a way that everyone can view and use it. To make this possible, we comply with the European Standard for accessibility EN 301 549. This standard is based on internationally recognised agreements regarding website accessibility, sustainability, interchangeability and findability.